To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
RoundTable acquires syringe maker
The Chicago firm's purchase of Excelsior Medical follows its successful exit of injectable generic drug maker Sabex to Novartis for $565m.
